1. P387 Different rate of transmural remission between first and second line of biologic treatment in Crohn's disease. (30th January 2023) Authors: De Sire, R; Rispo, A; Caiazzo, A; Testa, A; Nardone, O M; Guarino, A D; Olmo, O; Calabrese, G; Fierro, G; Toro, B; Cantisani, N M; Ferrante, M; La Mantia, A; D'Alessandro, E; Castiglione, F Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P442 Endoscopic resection of visible precancerous lesions in patients with colonic Inflammatory Bowel Disease. (30th January 2023) Authors: Busacca, A; De Sire, R; Capogreco, A; Dal Buono, A; Gabbiadini, R; Loy, L; Finati, E; Spadaccini, M; Maselli, R; Hassan, C; Repici, A; Armuzzi, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P522 Kono-S anastomosis reduces endoscopic and surgical post-operative recurrence in Crohn's disease. The SuPREMe-CD Trial Update. (30th January 2023) Authors: Luglio, G; Rispo, A; Tropeano, F P; Giglio, M C; Cricrì, M; Imperatore, N; De Sire, R; Guarino, A D; Bucci, L; Castiglione, F; De Palma, G D Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗